ALL NEW Gangnam Main Branch Director Dr. Kim Jung Eun Invited as Chair at Global Novo Nordisk Wegovy Symposium

Dr. Kim Jung Eun, Director of the ALL NEW Gangnam Main Branch, was invited to serve as Chairperson at the prestigious scientific symposium hosted by global pharmaceutical leader Novo Nordisk on Tuesday, August 26, held at JW Marriott Hotel Seoul.

📌 Event Details:

• Title: Wegovy Goes Beyond 2025 Symposium
• Date: Tuesday, August 26, 2025, 6:00 PM
• Venue: JW Marriott Hotel Seoul, Salon 1+2+3 (3F)

Renowned for its obesity treatments Wegovy and Saxenda, Novo Nordisk brought together leading experts to discuss the latest clinical evidence and future direction in obesity treatment, focusing on the weight-loss efficacy of Wegovy and its impact on major cardiovascular outcomes.

The symposium also included discussions on Mounjaro, the next-generation obesity treatment gaining global attention, further expanding the conversation around the shifting paradigm in obesity care.

As Chair of the symposium, Dr. Kim Jung Eun led the expert discussions, showcasing the medical leadership of 365mc and further solidifying Korea’s global influence in the field of obesity treatment.

365mc and Novo Nordisk have maintained a longstanding academic relationship.

Dr. Kim was previously invited as a keynote speaker at Novo Nordisk’s 2023 symposium, and in 2024, representatives from Novo Nordisk visited 365mc for a collaborative information session on Wegovy.

This ongoing academic exchange with a top global pharmaceutical company underscores both the influence of Dr. Kim Jung Eun—founder of LAMS—and 365mc’s role as a global standard-bearer in obesity treatment.

365mc remains committed to delivering the most advanced obesity treatment solutions to patients worldwide.

Thank you for your continued trust and support.